1. APIs
  2. Megestrol Acetate
  3. US FDA-Approved Products
  4. Megace ES

Megace ES

Product Category

US FDA-Approved Medicine

Formulation

MEGESTROL ACETATE: 125 mg/mL Oral suspension

Delivery Method

Oral Suspension

Status

Prescription

ANDA #

021778

Approval Date

20050705

Therapeutic Equivalents

Megestrol Acetate, #204688
Megestrol Acetate, #203139

Manufacturers

Endo Pharms Inc.

References

  1. Drugs@FDA Online Database (View all citations for this reference)